GAPDH and Hyperglycemia: Moreover, a reduction in GAPDH activity is considered a converging point of multiple deleterious pathways activated by hyperglycemia and a key step in the pathogenesis of DM complications [63]; therefore, the ability of HSPB1 to activate GAPDH may be particularly advantageous in DM.